Increases in GluA1 after SEFL treatment are prevented by metyrapone. (a) Experimental design. (b, d, f) Representative western blot images of GluA1, GluA2, GluN1, and GAPDH from the BLA of stressed and unstressed rats receiving vehicle or 150 mg/kg metyrapone. (c) Mean GluA1: GAPDH OD ratios (+SEM). Main effect of drug, p<0.005, **p<0.01 (one-way ANOVA, followed by a priori planned comparisons). (e) Mean GluA2: GAPDH OD ratios (+SEM). (g) Mean GluN1: GAPDH OD ratios (+SEM).